Till Seiler

1.9k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Till Seiler is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Till Seiler has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 7 papers in Immunology. Recurrent topics in Till Seiler's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Till Seiler is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Till Seiler collaborates with scholars based in Germany, United States and United Kingdom. Till Seiler's co-authors include Stephan Stilgenbauer, Hartmut Döhner, Alexander Kröber, Peter Lichter, Axel Benner, Lars Bullinger, Andreas Bühler, Dirk Winkler, Dirk Kienle and R. Kanti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Till Seiler

19 papers receiving 1.1k citations

Hit Papers

V H mutation status, CD38 expression level, genomic aberr... 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
    2002 597 citations Alexander Kröber, Till Seiler et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Till Seiler Germany 11 1000 757 588 196 150 19 1.1k
Andrew Greaves United States 11 1.1k 1.1× 780 1.0× 623 1.1× 241 1.2× 140 0.9× 23 1.2k
Lang Huynh United States 4 1.3k 1.3× 859 1.1× 765 1.3× 313 1.6× 153 1.0× 8 1.4k
Timothy J. Murphy United States 9 778 0.8× 799 1.1× 399 0.7× 192 1.0× 158 1.1× 19 1.2k
Jenny Orchard United Kingdom 11 1.6k 1.6× 1.3k 1.7× 808 1.4× 289 1.5× 158 1.1× 18 1.7k
Giuliana Strola Italy 9 569 0.6× 366 0.5× 464 0.8× 197 1.0× 106 0.7× 12 847
Matthew Kaufman United States 8 565 0.6× 368 0.5× 346 0.6× 148 0.8× 98 0.7× 26 723
Elisa Sozzi Italy 11 649 0.6× 471 0.6× 330 0.6× 174 0.9× 59 0.4× 19 749
Elisa ten Hacken United States 18 664 0.7× 346 0.5× 420 0.7× 333 1.7× 135 0.9× 36 941
Jennifer Edelmann Germany 12 812 0.8× 564 0.7× 352 0.6× 257 1.3× 135 0.9× 22 1.0k
John N. Allan United States 21 803 0.8× 708 0.9× 319 0.5× 206 1.1× 286 1.9× 97 1.1k

Countries citing papers authored by Till Seiler

Since Specialization
Citations

This map shows the geographic impact of Till Seiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Seiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Seiler more than expected).

Fields of papers citing papers by Till Seiler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Till Seiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Seiler. The network helps show where Till Seiler may publish in the future.

Co-authorship network of co-authors of Till Seiler

This figure shows the co-authorship network connecting the top 25 collaborators of Till Seiler. A scholar is included among the top collaborators of Till Seiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Till Seiler. Till Seiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jamasbi, Janina, Till Seiler, Hans Deckmyn, et al.. (2018). Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans. Blood. 131(24). 2605–2616. 69 indexed citations
2.
Pflug, Natali, Paula Cramer, Sandra Robrecht, et al.. (2018). New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance. Leukemia & lymphoma. 60(3). 649–657. 13 indexed citations
3.
Seiler, Till, Grit Hutter, & Martin Dreyling. (2016). The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date. Drugs. 76(6). 639–646. 16 indexed citations
4.
5.
Eisele, Lewin, Michael Möllmann, Andreas Hüttmann, et al.. (2013). Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia. PLoS ONE. 8(8). e72107–e72107. 28 indexed citations
6.
Seiler, Till, Roland C. Aydin, Tobias Herold, et al.. (2013). Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia. Blood. 122(21). 1619–1619. 1 indexed citations
7.
Herold, Tobias, Medhanie Mulaw, Vindi Jurinović, et al.. (2012). High expression ofMZB1predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature. Leukemia & lymphoma. 54(8). 1652–1657. 23 indexed citations
8.
Seiler, Till & Wolfgang Hiddemann. (2012). Advances in the management of follicular lymphoma. Current Opinion in Oncology. 24(6). 742–747. 10 indexed citations
9.
Herold, Tobias, Vindi Jurinović, Medhanie Mulaw, et al.. (2011). Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22‐23 in chronic lymphocytic leukemia—unexpected expression pattern of the RHO GTPase activator ARHGAP20. Genes Chromosomes and Cancer. 50(7). 546–558. 13 indexed citations
10.
11.
Seiler, Till, Wolfgang Hiddemann, & Martin Dreyling. (2009). Optimal Application of Antibodies in the Treatment of Follicular Lymphoma: Current Standards and Future Strategies. Immunotherapy. 1(6). 1015–1024. 1 indexed citations
12.
Seiler, Till, Sophia Yancopoulos, Rosa Catera, et al.. (2009). Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. Blood. 114(17). 3615–3624. 29 indexed citations
13.
Catera, Rosa, Gregg J. Silverman, Katerina Hatzi, et al.. (2008). Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation. Molecular Medicine. 14(11-12). 665–674. 150 indexed citations
14.
Seiler, Till, Rosa Catera, Hartmut Döhner, et al.. (2008). Induction of Apoptosis in CLL by Peptides Binding the B-Cell Antigen Receptor in Vitro. Blood. 112(11). 3151–3151. 1 indexed citations
15.
Catera, Rosa, Gregg J. Silverman, Katerina Hatzi, et al.. (2008). Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Catabolic Chemical Modifications. Blood. 112(11). 3150–3150. 1 indexed citations
16.
Kröber, Alexander, Johannes Bloehdorn, Sebastian Häfner, et al.. (2006). Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and V3-21 Usage Characterize Discordance of ZAP-70 and VH Mutation Status in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 24(6). 969–975. 134 indexed citations
17.
Kienle, Dirk, Axel Benner, Alexander Kröber, et al.. (2005). Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. Blood. 107(5). 2090–2093. 46 indexed citations
18.
Kröber, Alexander, Dirk Kienle, Dirk Winkler, et al.. (2004). ZAP-70 Expression, VH-Mutation Status, Genomic Aberrations and Prognosis in Chronic Lymphocytic Leukemia.. Blood. 104(11). 1920–1920. 2 indexed citations
19.
Kröber, Alexander, Till Seiler, Axel Benner, et al.. (2002). V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 100(4). 1410–1416. 597 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Greaves Breakdown of academic impact, for papers by Lang Huynh Breakdown of academic impact, for papers by Timothy J. Murphy Breakdown of academic impact, for papers by Jenny Orchard Breakdown of academic impact, for papers by Giuliana Strola Breakdown of academic impact, for papers by Matthew Kaufman Breakdown of academic impact, for papers by Elisa Sozzi Breakdown of academic impact, for papers by Elisa ten Hacken Breakdown of academic impact, for papers by Jennifer Edelmann Breakdown of academic impact, for papers by John N. Allan
Rankless by CCL
2026